After obtaining the approval documents for the production of Agatroban API and the first approved azithromycin dry suspension in China, Shijiazhuang No.4 Pharmaceutical Group achieved another success in product development. The two specifications of metronidazole sodium chloride injection (250ml: 1.25g and 100ml: 0.5g) in the polypropylene infusion bottle package applied for were approved for the production registration. The approval of this product will further enrich the packaging form of metronidazole product line to meet the needs of different clients.

It is reported that the approved product is to add plastic bottle packaging on the basis of the original multi-layer co extruded film infusion bag that passed the consistency evaluation. Metronidazole is a commonly used antibiotic, which is mainly used to treat or prevent systemic or local infections caused by anaerobic bacteria, and to treat anaerobic infections such as abdominal cavity, digestive tract, female reproductive system and oral cavity.  

At the same time, with the approval of the State Drug Administration, the Group can use its own raw materials of rosuvastatin calcium to produce corresponding preparations of rosuvastatin calcium tablets. Previously, the raw materials of rosuvastatin calcium and rosuvastatin calcium tablets declared by Shijiazhuang No.4 Pharmaceutical Group have obtained the production approval. Resuvastatin calcium is mainly used to treat primary hypercholesterolemia or mixed dyslipidemia.